Omaxe Limited carries a market capitalization of 13.85B, placing it among publicly traded companies globally. Its enterprise value stands at 12.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 13.85B |
| Enterprise Value | 12.66B |
Omaxe Limited currently has 182.90M shares outstanding.
| Shares Outstanding | 182.90M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.95, and the price-to-book ratio stands at 6.54.
| PE Ratio | N/A |
| PS Ratio | 0.95 |
| PB Ratio | 6.54 |
| P/TBV Ratio | -1.23 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
| EV / Sales | 1.01 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 6.40 |
Omaxe Limited maintains a current ratio of 0.97, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -164.27, indicating conservative leverage, while an interest coverage ratio of -2.86 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.97 |
| Quick Ratio | 0.09 |
| Debt / Equity | -164.27 |
| Debt / EBITDA | -2.01 |
| Interest Coverage | -2.86 |
| Return on Equity (ROE) | -356.08 |
| Return on Assets (ROA) | -4.44 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.15 |
| Income Tax | -2.02B |
| Effective Tax Rate | N/A |
Omaxe Limited's stock has declined approximately -24.52417% over the past 52 weeks. The 50-day moving average sits at 77.53, while the 200-day moving average is 78.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | -24.52417% |
| 50-Day Moving Average | 77.53 |
| 200-Day Moving Average | 78.23 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Omaxe Limited generated 12.53B in revenue and converted that into -6.97B in net income, yielding earnings per share of -38.11. EBITDA reached -7.30B, while operating income came in at -7.30B.
| Revenue | 12.53B |
| Gross Profit | -5.08B |
| Operating Income | -7.30B |
| Pretax Income | -8.99B |
| Net Income | -6.97B |
| EBITDA | -7.30B |
| EBIT | -7.30B |
| Earnings Per Share (EPS) | -38.11 |
Omaxe Limited holds 14.05B in cash and equivalents against 14.66B in total debt, resulting in a net debt position of 9.35B. Total book value stands at 1.83B, with working capital of -5.32B providing operational flexibility.
| Cash & Cash Equivalents | 14.05B |
| Total Debt | 14.66B |
| Net Debt | 9.35B |
| Equity (Book Value) | 1.83B |
| Book Value Per Share | 10.00 |
| Working Capital | -5.32B |
Omaxe Limited operates with a gross margin of -40.57, reflecting its pricing power and cost economics. The operating margin of -58.27 and net profit margin of -55.60 provide insight into operational efficiency.
| Gross Margin | -40.57 |
| Operating Margin | -58.27 |
| Pretax Margin | -71.74 |
| Profit Margin | -55.60 |
| EBITDA Margin | -58.27 |
Omaxe Limited's most recent stock split took place on November 11, 2013 with a 1000000:1256423 split ratio.
| Last Split Date | 11/11/2013 |
| Split Ratio | 1000000:1256423 |
Omaxe Limited posts an Altman Z-Score of -0.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -0.07 |